Vytrus Biotech S.A.
Research Vytrus Biotech S.A. (VYT) on Bullrun: market cap EUR 117.26M, P/E 40.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVYT
- ExchangeMC
- CountrySpain
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 117.26M
- P/E40.5
- Financial periodFY2025
- RevenueEUR 8.37M
- Revenue growth66.0%
- Net incomeEUR 2.90M
- Free cash flowEUR 1.22M
- Gross margin105.5%
Valuation Snapshot
latest market cap is EUR 117.26M; P/E is 40.5.
Peer valuation comparison
Latest P/E is 40.48x versus a Healthcare sector median of 24.46x (65.5% above).
Latest P/E is 40.48x versus a Spain median of 15.76x (156.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 8.37M | EUR 2.90M | EUR 1.22M | 105.5% | n/a | EUR 3.38M | EUR 1.97M | EUR 10.31M |
| FY2024 | EUR 5.04M | EUR 1.02M | EUR 640.24K | 109.0% | n/a | EUR 2.53M | EUR 2.48M | EUR 7.29M |
| FY2023 | EUR 3.74M | EUR 544.94K | -EUR 261.83K | 116.4% | 0.08 | EUR 1.10M | EUR 2.85M | EUR 5.29M |
| FY2022 | EUR 3.68M | EUR 605.26K | -EUR 268.62K | 112.2% | 0.09 | EUR 724.62K | EUR 2.02M | EUR 4.75M |
| FY2021 | n/a | n/a | n/a | n/a | 0.06 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 117.26M | 40.5 | n/a | n/a |
About Vytrus Biotech S.A.
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. It offers Clarivine that activates skin's regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota; Deobiome Noni, a prebiotic deodorant to reduce the generation of body odour; Sarcoslim Re-Shape, an active ingredient to reduce fat on tissue; Capilia Longa that improves density in hair, eyebrows, and eyelashes;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Vytrus Biotech S.A.'s market cap?
Vytrus Biotech S.A.'s market capitalization is EUR 117.26M.
What is Vytrus Biotech S.A.'s P/E ratio?
Vytrus Biotech S.A.'s price-to-earnings (P/E) ratio is 40.5.
What does Vytrus Biotech S.A. do?
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. It offers Clarivine that activates skin's regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota; Deobiome Noni, a prebiotic deodorant to reduce the generation of body odour; Sarcoslim Re-Shape, an active ingredient to reduce fat on tissue; Capilia Longa that improves density in hair, eyebrows, and eyelashes; and Luminia Granatum that brightens skin, whitens dark spots, evens skin tone, and protects against oxidative stress.